Basal-Supported Oral Therapy with Sitagliptin Counteracts Rebound Hyperglycemia Caused by GLP-1 Tachyphylaxis

Introduction. Treatment with a glucagon-like peptide 1 (GLP-1) analog fails in some patients due to rebound hyperglycemia caused by tachyphylaxis (GLP-1 tachyphylaxis). We investigated the efficacy of basal-supported oral therapy (BOT) with insulin glargine and sitagliptin for counteracting GLP-1 ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Meguro, Shu, Kawai, Toshihide, Matsuhashi, Tomohiro, Sano, Motoaki, Fukuda, Keiichi, Itoh, Hiroshi, Suzuki, Yoshihiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967600/
https://www.ncbi.nlm.nih.gov/pubmed/24738001
http://dx.doi.org/10.1155/2014/927317

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3967600/
https://www.ncbi.nlm.nih.gov/pubmed/24738001
http://dx.doi.org/10.1155/2014/927317

Ejemplares similares